Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v21.i23.7320 http://scihub22266oqcxt.onion/10.3748/wjg.v21.i23.7320 C4476896!4476896!26109821     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Gastroenterol 2015 ; 21 (23): 7320-5 Nephropedia Template TP {{tp|p=26109821|t=2015. How to treat an extensive form of primary intestinal lymphangiectasia?|pdf=|usr=}}{{26109821}} gab.com Text How to treat an extensive form of primary intestinal lymphangiectasia JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26109821 #FOAvip We report a case of a 42-year-old man with a rare disorder known as primary intestinal lymphangiectasia, which is characterized by dilated intestinal lymphatics that lead to the development of protein-losing enteropathy. The patient presented with a grand mal seizure caused by malabsorption-derived electrolytes and a protein disorder. Signs of the disease, including chronic diarrhea and peripheral edema, manifested 10 years ago, but a diagnosis was never made. The diagnosis was suspected because of the clinical manifestations, laboratory tests, imaging and endoscopic findings. Hyperemic and edematous mucosa of the small intestine corresponded to scattered white spots with dilated intestinal lymphatics and whitish villi in the histological specimen of the biopsied jejunal mucosa. Although numerous therapeutic strategies are available, only octreotide therapy proved to be an effective means of therapeutic resolution in this patient. Although the patient had a partial remission following the use of a slow release formula of octreotide, his prognosis, clinical course, and future treatment challenges are yet to be determined. Twit Text FOAVip How to treat an extensive form of primary intestinal lymphangiectasia ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=26109821 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26109821 #FOAvip English Wikipedia <ref>{{Cite pmid|26109821}}</ref> How to treat an extensive form of primary intestinal lymphangiectasia? #MMPMID26109821 Troskot R; Jur?i? D; Bili? A; Gomer?i? Pal?i? M; Te?ak S; Brajkovi? I World J Gastroenterol 2015[Jun]; 21 (23): 7320-5 PMID26109821show ga We report a case of a 42-year-old man with a rare disorder known as primary intestinal lymphangiectasia, which is characterized by dilated intestinal lymphatics that lead to the development of protein-losing enteropathy. The patient presented with a grand mal seizure caused by malabsorption-derived electrolytes and a protein disorder. Signs of the disease, including chronic diarrhea and peripheral edema, manifested 10 years ago, but a diagnosis was never made. The diagnosis was suspected because of the clinical manifestations, laboratory tests, imaging and endoscopic findings. Hyperemic and edematous mucosa of the small intestine corresponded to scattered white spots with dilated intestinal lymphatics and whitish villi in the histological specimen of the biopsied jejunal mucosa. Although numerous therapeutic strategies are available, only octreotide therapy proved to be an effective means of therapeutic resolution in this patient. Although the patient had a partial remission following the use of a slow release formula of octreotide, his prognosis, clinical course, and future treatment challenges are yet to be determined. äHow to treat an extensive form of primary intestinal lymphangiectasia?(epmc).pdf DeepDyve Pubget Overpricing